CA
ATXS

Cliff Asness’s Astria Therapeutics ATXS Stock Holding History

Cliff Asness’s Portfolio ATXS Stock Details ATXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-12,790
Closed -$95.4K – 2331
2023
Q3 		$95.4K Buy
+12,790
New +$109K ﹤0.01% 2235
2021
Q3 		– Sell
-5,232
Closed -$66K – 2244
2021
Q2 		$66K Sell
5,232
-844
-14% -$11K ﹤0.01% 2203
2021
Q1 		$105K Sell
6,076
-14,064
-70% -$254K ﹤0.01% 2152
2020
Q4 		$259K Buy
+20,140
New +$359K ﹤0.01% 2015

Other funds holding ATXS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return

Cliff Asness's ATXS Position: Q4 2023 in Review

Cliff Asness sold out of Astria Therapeutics (ATXS) in Q4 2023, closing a stake of 12,790 shares — an estimated $95.4K sold.

Cliff Asness first reported a position in ATXS in Q4 2020 and held it in 4 quarters. The position peaked at $259K in Q4 2020. 80 funds tracked by Wall St. Rank hold ATXS as of Q4 2023.

  • Cliff Asness reported no remaining Astria Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Cliff Asness sold 12,790 Astria Therapeutics shares in Q4 2023, an estimated $95.4K.
  • Cliff Asness first reported a position in Astria Therapeutics in Q4 2020 and held it in 4 quarters.
  • Cliff Asness's Astria Therapeutics position peaked at $259K in Q4 2020.
  • 80 funds tracked by Wall St. Rank held Astria Therapeutics as of Q4 2023.

Based on AQR Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.